Uklad genetyczny a odpowiedz metaboliczna na zmiany skladu diety

• Autorzy: Nowicka G

Warianty tytułu

EN

Genotype and metabolic response to dietary changes

• Języki publikacji: PL

Słowa kluczowe

PL

zywienie czlowieka; sposob zywienia; metabolizm czlowieka; polimorfizm genow; apolipoproteiny; lipoproteiny; witamina D; dieta; cholesterol; kwasy tluszczowe; kwas foliowy; przyswajalnosc wapnia; badania genetyczne; choroby czlowieka

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2000
• Tom: 27
• Numer: 3
• Opis fizyczny: s.277-286,bibliogr.

Twórcy

autor

Nowicka G

• Instytut Zywnosci i Zywienia w Warszawie, Warszawa

Bibliografia

• 1. Argen J.J., Valve R., Vidregen H., et al.: Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid binding protein 2 gene. Arterioscler. Thromb. Vase. Biol., 1998, 18, 1606.
• 2. Baier L.J., Sechettini J.C., Knowler W.C.: An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J. Clin. Invest. 1995, 95, 1281.
• 3. Boerwinkle E., Brown S., Shareft A.R., et al.: Apolipoprotein E polimorphism influences postprandial retinyl palmitate but not trigliceryde concentration. Am. J. Hum. Genet., 1994, 54, 341.
• 4. Cobb M.M., Teitlebaum H., Risch N.: Influence of dietary fat, apolipoprotein E phenotype and sex on plasma lipoprotein levels. Circulation 1992, 86, 849.
• 5. Cooper G.S., Umbach D.M.: Are vitamin D receptor polymorphism associated with bone mineral density? A meta-analysis. J. Bone Miner. Res., 1996, 11, 1841.
• 6. Cusi D., Barlassina C., Azzani T., et al.: Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997, 349, 1353.
• 7. Dowson- Hughes B., Harris S., Finneran S.: Calcium absorption on high and low calcium intakes in relation to vitamin D receptor gene. J. Clin. Endocrinol. Metab., 1995, 80, 3657.
• 8. Fisher R.M., Burke H., Nicaud V., et al.: Effect of variation in the apo AIV gene on body mass index, and fasting and postprandial lipids in the European Atherosclerosis Research Study II. J. Lipid Res., 1999, 40, 287.
• 9. Fujimoto K., Machidori H., Iwakiri, et al.: Effect of intravenous administration of apolipoprotein AIV on patterns of feeding, drinking and ambulatory activity in rats. Brain Res., 1993, 608, 233.
• 10. Gerhard G.T., Duell P.B.: Homocysteine and atherosclerosis. Curr. Opin. Lipidol., 1999, 10, 417.
• 11. Girard J., Ferre P., Fonfelle F.: Mechanisms by which carbohydrates regulate expression of genes for glycolytic and lipogenic enzymes. Annu. Rev. Nutr., 1997, 17, 325.
• 12. Gylling H., Kontula K., Koivisto U.M., et al.: Polimorphism of the genes encoding apolipoproteins AI, B, CIII, and E and LDL receptor, and cholesterol and LDL metabolism during increased cholesterol intake. Arterioscler. Thromb. Vasc. Biol., 1997, 17, 38.
• 13. Hegele R.A., Wolever T.M., Story A., et al.: Intestinal fatty acid binding protein variation associated with variation in the response of plasma lipoproteins to dietary fibre. Eur. J. Clin. Invest., 1997, 27, 857.
• 14. Humphries S.E., Nicaud V., Margalef J., et al.: Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglicerydes. EARS Study. Arterioscler. Thromb. Vase. Bio., 1998, 18, 526.
• 15. Jenkins D.Y., Hegele R.A., Jenkins A.L.: The apolipoprotein E gene and the serum low density lipoprotein cholesterol response to dietary fiber. Metabolism 1993, 42, 585.
• 16. Jump D.B., Clarce S.D.: Regulation of gene exspression by dietary fat. Annu. Rev. Nutr., 1999, 19, 63.
• 17. Kesaniemi Y.A., Ehnholm C., Mittinen T.A.: Intestinal cholesterol absorption efficiency in man is related to apolipoprotein E phenotype. J. Clin. Invest., 1987, 80, 578.
• 18. Kirke P.N., Mills J., Whitehead S., et al.: Methylenetetrahydrofolate reductase mutation and neural tube defects. Lancet 1996, 348, 1037.
• 19. Kłosiewicz L., Nowicka G., Grzybek A., et al.: Hypolipemic diet effect on lipoprotein profile in patients with hypercholesterolemia and mixed hyperlipidaemia in relation to apoE phenotype. Med. Sci. Monit., 1999, 5, 62.
• 20. Law M.: Salt, blood pressure and cardiovascular disease. J. Cardiol. Risk., 2000, 7, 5.
• 21. Loktinov A., Bingham S.A., Vorster H., et al.: Apolipoprotein E genotype modulates the effect of black tea drinking on blood lipids and blood coagulation factors: a pilot study. Br. J. Nutr., 1998, 79, 133.
• 22. Lopez-Miranda J., Jansen S., Ordovas J.M., et al.: Influence of the Sstl polymorphism at the apolipoprotein CIII gene locus on the plasma low-density lipoprotein cholesterol response to dietary monounsaturated fat. Am. J. Clin. Nutr., 1997, 66, 97.
• 23. Lopez-Miranda J., Ordovas J.M., Ostos M.A., et al.: Effect of the human apolipoprotein AI promoter G/A mutation on postprandial lipoprotein metabolism. Circulation 92, Suppl I, 156 (abstract).
• 24. Mager A., Lalezari S., Shohat T., et al.: Methylenetetrahydrofolate reductase genotypes and early onset coronary artery disease. Circulation 1999, 100, 2406.
• 25. Malloy A.M., Daly S., Mills J., et al.: Thermolabile variant of 5,10-methylene-tetrahydrofolate reductase associated with low red cell folates: implications for folate intake recommendations. Lancet 1997, 349, 1591.
• 26. Marshall J.A., Kamboh M.I., Bessesen D.H., et al.: Association between dietary factors and serum lipids by apolipoprotein E polimorphism. Am. J. Clin. Nutr., 1996, 63, 87.
• 27. Mata P., Ordovas J.M., Lopez-Miranda J., et al.: Apo AIV phenotype effects diet-induced plasma LDL cholesterol lowering. Arterioscler. Thromb. 1994, 14, 884.
• 28. McCombs R.J., Marcadis D.E., Ellis J., et al.: Attenuated hypercholesterolemic response to a high-cholesterol diet in subjects heterozygous for the apolipoprotein AIV-2 allele. N. Engl. J. Med., 1994, 331, 706.
• 29. Mettinen T.A., Gylling H., Vanhanent H., et al.: Cholesterol absorption, elimination and synthesis related to LDL kinetics during varying fat intake in men with different apolipoprotein phenotypes. Arterioscler. Thromb., 1992, 12, 1044.
• 30. Morton N.M., Emilsson V., Lin Y., et al.: Leptin action i intestinal cells. J. Biol. Chem., 1998, 273, 26194.
• 31. Nowicka G.: Apolipoproteina E - białko odgrywające szczególną rolę w etiopatogenezie typu III HLP. Żyw. Człow Metab., 1988, 15, 56.
• 32. Nowicka G.: Lipoproteiny o wysokiej gęstości i ich rola w zwrotnym transporcie cholesterolu. Czyn. Ryz., 1993, 2, 18.
• 33. Nowicka G.: Współczesne spojrzenie na antyaterogenne działanie lipoprotein o wysokiej gęstości. Czyn. Ryz., 1998, 4, 12.
• 34. Ordovas J.M., Galluzzi J.R.: Genetic predictors of plasma lipid response to diet intervention. Curr. Atheroscler, Reports 1999, 1, 196.
• 35. Ordovas J., Miranda J., Mata P., et al.: Gen-diet interaction in determining lipid response to dietary intervention. Atherosclerosis 1995, 118, Suppl S11.
• 36. Pimstone S.N., Clee S.M., Gange S.E., et al.: A frequently occuring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postpradial chylomicron trigliceryde and retinyl palmitate response in normolipidemic carriers. J. Lipid. Res., 1996, 37, 1675.
• 37. Sainz J., Van Tornout J., Lord L., et al.: Vitamin D receptor gene polymorphism and bone density in prepubertal american girls of emexican descent. N. Engl. J. Mmed, 1997, 337, 77.
• 38. Salas J., Jansen S., Lopez-Miranda J., et al.: The Sstl polymorphism of the apolipoprotein CIII gene determines the insulin response to an oral glucose tolerance test after consumptoon of a diet rich in saturated fats. Am. J. Clin. Nutr., 1998, 68, 396.
• 39. Schroeder F., Jolly C.A., Cho T., et al.: Fatty acid binding isoform: structure and function. Chem. Phys. Lipids 1998, 92, 1.
• 40. Sigurdsson G., Gudnason V., Humphries S.E.: Interaction between a polymorphism of the apoAl promoter region and smoking determines plasma levels of HDL and apo Al. Arterioscler. Thromb., 1992, 12, 1017.
• 41. Steinmetz A., Barbaras R., FGGhalim N., et al.: Human apolipoprotein AIV binds to apolipoprotein AI/AII receptor sites and promotes cholesterol efflux from adipose cells. J. Biol. Chem., 1990, 265, 7859.
• 42. Tikkanen M.J., Xu C.F., Hamalainen T., et al.: Xabl polimoprphism of the apolipoprotein B gene influences plasma lipid response to diet intervention. Clin. Genet., 1990, 37, 327.
• 43. Tiret L., de Knijff P., Menzel H.J., et al.: Apo E polymorphism and predisposition to coronary heart disease in youths of different european populations. The EARS Study. Arterioscler.Thromb. Vase. Biol., 1994, 14, 1617.
• 44. Tso P., Min Lin, Kologeris T.J.: The role of apolipoprotein AIV in food intake regulation. J. Nutr., 1999, 129, 1503.
• 45. Van Nieuwenhoven F.A., Van der Vusse G.J., Glatz J.F.: Membrane associated and cytoplasmic fatty acid binding proteins. Lipids 1996, 31, Suppl, S223.
• 46. Wang C.S., McConathy W.Y., Kloer H.U., et al.: Modulation of lipoprotein lipase activity by lipoproteins. Effect of apolipoprotein CIII. J. Clin. Invest., 1985, 75, 384.
• 47. Waterworth D.M., Ribalto J., Nicaud V., et al.: Apo CIII gene variants modulate postprandial response to both glucose and fat tolerance tests. Circulation 1999, 99, 1872.
• 48. Weisgraber K.H., Mahley R.W., Kowal R.C., et al.: Apolipoprotein C modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins and inhibits binding of beta-VLDL to low density lipoprotein receptor - related protein. J. Biol. Chem., 1990, 265, 22453.
• 49. Wilson P., Schaefer E., Iarson M., et al.: Apolipoprotein E alleles and risk of coronary artery disease. A metaanalysis. Arterioscler. Thromb. Vase. Biol., 1996, 16, 1250.
• 50. Wittrup H.H., Tybjaerg-Hansen A., Steffensen R.: Mutations in the lipoprotein lipase gene associated with ischemic heart disease in men. The Copenhagen City Heart Study. Arterioscler. Thromb. Vasc. Biol., 1999, 19, 1535.
• 51. Wittrup H.H., Tybjaerg-Hansen A., Nordesgard B.G.: Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A metaanalysis. Circulation 1999, 99, 2901.
• 52. Yamada K., Yuan X., Ishiyema S.: Association between Ala54Thr substitution of the fatty acid binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia 1997, 40, 706.